These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 14689232

  • 1. Pulmonary nocardiosis in a patient with CML relapse undergoing imatinib therapy after bone marrow transplantation.
    Lin JT, Lee MY, Hsiao LT, Yang MH, Chao TC, Chen PM, Chiou TJ.
    Ann Hematol; 2004 Jul; 83(7):444-6. PubMed ID: 14689232
    [Abstract] [Full Text] [Related]

  • 2. Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD.
    Bhave AA, Thirunavukkarasu K, Gottlieb DJ, Bradstock K.
    Bone Marrow Transplant; 1999 Mar; 23(5):519-21. PubMed ID: 10100569
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disseminated nocardiosis after unrelated bone marrow transplantation.
    Hino Y, Doki N, Senoo Y, Sekiya N, Kurosawa S, Tsuboi S, Ohashi K.
    Transpl Infect Dis; 2016 Dec; 18(6):942-945. PubMed ID: 27696601
    [Abstract] [Full Text] [Related]

  • 5. Clinical features and successful recovery from disseminated nocardiosis after BMT.
    Machado CM, Macedo MC, Castelli JB, Ostronoff M, Silva AC, Zambon E, Massumoto C, Chamone DF, Dulley FL.
    Bone Marrow Transplant; 1997 Jan; 19(1):81-2. PubMed ID: 9012936
    [Abstract] [Full Text] [Related]

  • 6. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, Galinsky I, Parekkedon B, Ritz J, Antin JH, Stone RM, Soiffer RJ.
    Clin Cancer Res; 2004 Aug 01; 10(15):5065-71. PubMed ID: 15297408
    [Abstract] [Full Text] [Related]

  • 7. [Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].
    Canet S, Garrigue V, Bismuth J, Chong G, Lesnik A, Taourel P, Mourad G.
    Nephrologie; 2004 Aug 01; 25(2):43-8. PubMed ID: 15119219
    [Abstract] [Full Text] [Related]

  • 8. Disseminated subcutaneous Nocardia asteroides abscesses in a patient after bone marrow transplantation.
    Hodohara K, Fujiyama Y, Hiramitu Y, Sumiyoshi K, Kitoh K, Hosoda S, Sugiura H.
    Bone Marrow Transplant; 1993 Apr 01; 11(4):341-3. PubMed ID: 8485481
    [Abstract] [Full Text] [Related]

  • 9. Frequent exacerbation of pulmonary nocardiosis during maintenance antibiotic therapies in a hematopoietic stem cell transplant recipient.
    Kakihana K, Ohashi K, Iguchi M, Negishi K, Suzuki T, Shitara M, Honma M, Akiyama H, Sakamaki H.
    Int J Hematol; 2007 Dec 01; 86(5):455-8. PubMed ID: 18192116
    [Abstract] [Full Text] [Related]

  • 10. An HIV-infected patient with Nocardia asteroides bilateral pneumonia.
    Unkle DW, Ricketti AJ, Cleri DJ, Moser RL, Vernaleo JR.
    AIDS Read; 2008 Nov 01; 18(11):566-8. PubMed ID: 19062401
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary nocardiosis after bone marrow transplantation successfully treated with doxycycline.
    Kumar K, Jimenez V.
    Int J Infect Dis; 2001 Nov 01; 5(4):222-4. PubMed ID: 11953222
    [No Abstract] [Full Text] [Related]

  • 12. Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis.
    Leis JF, Primack SL, Schubach SE, Curtin PT, Druker BJ, Maziarz RT.
    Haematologica; 2004 Sep 01; 89(9):ECR30. PubMed ID: 15377482
    [Abstract] [Full Text] [Related]

  • 13. Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation.
    Vandenberghe P, Boeckx N, Ronsyn E, Decorte R, Verhoef G, Hagemeijer A.
    Leukemia; 2003 Feb 01; 17(2):458-60. PubMed ID: 12592347
    [No Abstract] [Full Text] [Related]

  • 14. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Campione E, Diluvio L, Paternò EJ, Di Marcantonio D, Francesconi A, Terrinoni A, Orlandi A, Chimenti S.
    Clin Ther; 2009 Nov 01; 31(11):2565-9. PubMed ID: 20110001
    [Abstract] [Full Text] [Related]

  • 15. New strategies in controlling drug resistance.
    Frame D.
    J Manag Care Pharm; 2007 Oct 01; 13(8 Suppl A):13-7. PubMed ID: 17970610
    [Abstract] [Full Text] [Related]

  • 16. [Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase].
    Gao GL, Xu N, Zhou X, Xiao YJ, Ding L, Lu QS, Wei YQ, Zhang Y, Xu D, Sun J, Liu QF, Liu XL.
    Zhonghua Yi Xue Za Zhi; 2013 Oct 15; 93(38):3035-9. PubMed ID: 24417923
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary nocardiosis in a patient with idiopathic thrombocytopenic purpura.
    Cokkinos DD, Spanou E, Giannou S, Protopapa E, Kyriakou L, Mantzoukis D.
    J Infect; 2006 Feb 15; 52(2):e41-3. PubMed ID: 15996740
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
    Yamasawa H, Sugiyama Y, Bando M, Ohno S.
    Respiration; 2008 Feb 15; 75(3):350-4. PubMed ID: 16449804
    [Abstract] [Full Text] [Related]

  • 19. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.
    Thirman MJ, Devine SM, O'Toole K, Cizek G, Jessurun J, Hertz M, Geller RB.
    Bone Marrow Transplant; 1992 Sep 15; 10(3):307-11. PubMed ID: 1422484
    [Abstract] [Full Text] [Related]

  • 20. Cerebral nocardiosis after allogeneic bone marrow transplantation.
    Carradice D, Szer J.
    Intern Med J; 2004 Dec 15; 34(12):698-9. PubMed ID: 15610216
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.